Regenxbio (RGNX) Non-cash Items (2014 - 2025)
Regenxbio (RGNX) recorded quarterly Non-cash Items of $8.0 million in Q4 2025, up 3.38% quarter-over-quarter from $7.7 million in Q3 2025, and up 3213.75% on a YoY basis from $240000.0 in Q4 2024.
Regenxbio (RGNX) Non-cash Items (2014 - 2025) Analysis & Trends
Regenxbio's Non-cash Items history runs 12 years deep, the most recent figure standing at $8.0 million for Q4 2025.
- In Q4 2025, Non-cash Items rose 3213.75% year-over-year to $8.0 million; the TTM figure through Dec 2025 stood at $8.0 million (up 3213.75% YoY), while the FY2025 annual figure was $8.0 million, up 16.32% from the prior year.
- Non-cash Items was $8.0 million for Q4 2025 at Regenxbio, up from $7.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $74.1 million in Q3 2021 to a low of $84000.0 in Q1 2025.
- Historically, Non-cash Items has averaged $14.7 million across 5 years, with a median of $6.4 million in 2023.
- Biggest YoY gain for Non-cash Items was 3213.75% in 2025; the steepest drop was 98.67% in 2025.
- A 5-year view of Non-cash Items shows it stood at $41.1 million in 2021, then plunged by 61.62% to $15.8 million in 2022, then slumped by 55.58% to $7.0 million in 2023, then tumbled by 96.58% to $240000.0 in 2024, then soared by 3213.75% to $8.0 million in 2025.
- The last three Non-cash Items figures came in at $8.0 million (Q4 2025), $7.7 million (Q3 2025), and $737000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Regenxbio | 325.94 Mn | 95.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.95 Mn |
| Dec 31, 2025 | 7.95 Mn |
| Sep 30, 2025 | 7.69 Mn |
| Sep 30, 2025 | 7.69 Mn |
| Jun 30, 2025 | 737,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 84,000.00 |
| Mar 31, 2025 | 84,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Sep 30, 2024 | 6.61 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 6.32 Mn |
| Mar 31, 2024 | 6.32 Mn |
| Dec 31, 2023 | 7.01 Mn |
| Dec 31, 2023 | 7.01 Mn |
| Sep 30, 2023 | 6.44 Mn |
| Sep 30, 2023 | 6.44 Mn |